•Combination treatment with anti-CTLA-4 mAb and MUC1 mRNA nanovaccine could appear more effective than either nanovaccine or anti-CTLA-4 mAb alone at increasing level of apoptosis in tumor cells. This evidence concerns the gene CTLA4 and neoplasm.